<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2018.813130</article-id><article-id pub-id-type="publisher-id">OJOG-88267</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  First Experience Using Brazilian Ingamed&lt;sup&gt;&amp;reg&lt;/sup&gt; Cervical Pessary in Twin Pregnancy: A Case Series
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Janete</surname><given-names>Vettorazzi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cristiano</surname><given-names>Caetano Salazar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edimárlei</surname><given-names>Gonsales Valério</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ana</surname><given-names>Lúcia Isotton</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anthomy</surname><given-names>Petermann</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marcos</surname><given-names>Wengrover Rosa</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gabriela</surname><given-names>Francoes Rostirolla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Gynecology and Obstetrics, Medical School of UFRGS, Porto Alegre, Brazil</addr-line></aff><aff id="aff1"><addr-line>Postgraduation Program in Health Sciences, Gynecology and Obstetrics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil</addr-line></aff><aff id="aff4"><addr-line>Medicina Fetal Porto Alegre, Porto Alegre, Brazil</addr-line></aff><aff id="aff5"><addr-line>Service of Obstetrics and Gynecology, Hospital Moinhos de Vento, Porto Alegre, Brazil</addr-line></aff><aff id="aff2"><addr-line>Service of Gynecology and Obstetrics, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil</addr-line></aff><pub-date pub-type="epub"><day>29</day><month>10</month><year>2018</year></pub-date><volume>08</volume><issue>13</issue><fpage>1282</fpage><lpage>1288</lpage><history><date date-type="received"><day>3,</day>	<month>September</month>	<year>2018</year></date><date date-type="rev-recd"><day>29,</day>	<month>October</month>	<year>2018</year>	</date><date date-type="accepted"><day>1,</day>	<month>November</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   The rate of prematurity in twin pregnancies is higher than 50%.
   
  Due to its multifactorial nature, different strategies are necessary to reduce the incidence of premature birth or to increase the gestational age at birth of pregnancies at risk. In this context, cervical pessary may be indicated in twin pregnancies with short cervix.
   
  <b>Methods:</b>
   In this
   
  case series, we describe six twin pregnancies that were considered as high-risk for preterm labor due to short cervix (CL &lt; 30 mm)
   
  at second trimester and multiple risk factors for prematurity. Several strategies were associated for the goal of delaying gestational age at birth. The main strategies were: removal of labor activities, treatment of infections, vaginal micronized progesterone 400 mg/day and vaginal pessary insertion (Ingamed&lt;sup&gt;&amp;reg&lt;/sup&gt;
   Brazil). <b>Results:</b> The gestational age of insertion of the pessary ranged from 16 to 24 weeks. The gestational age of birth ranged from 26 to 34 weeks. Three of the pregnancies were delivered due to spontaneous onset of labor, and three were delivered due to medical reasons. The mean length of pregnancy since pessary insertion to birth was 9 weeks (range 2 to 17 weeks). All infants without severe fetal malformation were discharged from the hospital without major sequelae. <b>Conclusion:</b> The use of cervical pessaries associated to micronized progesterone at a dose of 400 mg/day may be an option in the management of twins at risk for preterm birth. More controlled studies are needed to evaluate the simultaneous use of cervical pessary and progesterone on twin pregnancies.
 
</p></abstract><kwd-group><kwd>Cervical Pessary</kwd><kwd> Ingamed Pessary</kwd><kwd> Progesterone</kwd><kwd> Twin Pregnancy</kwd><kwd> Preterm Birth</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The number of twin births has increased in recent years [<xref ref-type="bibr" rid="scirp.88267-ref1">1</xref>] . About 50% of these are born before 37 weeks, which implies important fetal morbidity and mortality. As prematurity can be considered a multifactorial syndrome, preventive measures and management of cases at risk usually include actions related to the main contributing factors for preterm labor. One of the several factors which increase preterm birth is the presence of short cervix. Shortening of the cervical length (CL) is a predictor of preterm birth in singleton and twin pregnancies. The risk of preterm delivery is inversely related to cervical length (CL) assessed at 22 - 26 weeks of gestation, and a CL ≤ 25 mm is associated with 28% risk for birth before 28 weeks [<xref ref-type="bibr" rid="scirp.88267-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref3">3</xref>] . The cut-off measure to classify a cervix as short in the second trimester is controversial for twin pregnancies. Different studies describe cut-off measures of 38 mm, 30 mm or 25 mm [<xref ref-type="bibr" rid="scirp.88267-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref6">6</xref>] . In our clinical practice, a CL below 30 mm in twin pregnancies is considered as short. The cervical length is not routinely measured in Brazil’s public health care system, and there is no national recommendation on this topic. Nevertheless, the medical staff responsible for the prenatal care of the patients described on this paper followed the International Society of Ultrasound in Obstetrics and Gynecology guidelines [<xref ref-type="bibr" rid="scirp.88267-ref7">7</xref>] . Currently, there are different strategies to manage twin pregnancies with short cervix (TPSC), most of them with no proven effectiveness. Cervical cerclage has been associated with increase in the frequency of adverse outcomes in twin pregnancies [<xref ref-type="bibr" rid="scirp.88267-ref8">8</xref>] . A systematic review and meta-analysis showed that vaginal progesterone reduced the rate of preterm delivery in TPSC [<xref ref-type="bibr" rid="scirp.88267-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref10">10</xref>] . Likewise, a randomized study associated the use of cervical pessary in twin pregnancies of mothers with a short cervix with significant reduction of prematurity [<xref ref-type="bibr" rid="scirp.88267-ref9">9</xref>] . In other recent meta-analysis, intravaginal progesterone 400 mg/day was more effective than in the doses of 100 or 200 mg in cases of TPSC [<xref ref-type="bibr" rid="scirp.88267-ref11">11</xref>] .</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>In this case series we describe six twin pregnancies that were considered as high-risk for preterm labor due to short cervix (CL &lt; 30 mm) at second trimester. The patients were selected from one of the authors’ private clinic (J.V.), after screening for short cervix on second trimester.</p><p>Cervical length was obtained between 20 and 24 weeks of pregnancy by transvaginal ultrasound, using a General Electric (GE) VOLUSON E8, with an endocavity transducer at a frequency of 7.5 MHz. Ultrasound was performed with the patient in a dorsal lithotomy position and with empty bladder. The cervix was measured along its longitudinal axis. The cervix occupied approximately 50% - 75% of the image and pressure from the probe on the cervix was as little as possible. Cervical measurement was obtained by placing calipers at the external and internal OS, using a straight line between both of them. If the cervix was curved and the straight-line cervical length measurement was short, measurement obtained in two or more segments was performed to provide a more accurate estimation. The examination lasted from 3 to 5 minutes to detect possible changes in cervical length, and at least 3 measurements were obtained along that period.</p><p>The patients were managed on an individual basis. Some of them had multiple risk factors for prematurity, mostly previous infections. All patients had a cervical pessary (Ingamed<sup>&#210;</sup> Brazil) inserted, received vaginal micronized progesterone at a dose of 400 mg/day and were removed from their work activities. The main baseline characteristics, CL, gestational age at pessary insertion and individual risk factors are described on <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3"><title>3. Results and Discussion</title><p>The main maternal and fetal outcomes are described on <xref ref-type="table" rid="table1">Table 1</xref>. The mean CL and gestational age at pessary insertion were respectively 21 mm (range 10 - 28 mm) and 22 weeks (range 16 - 24 weeks). Mean age of delivery was 31 weeks</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Case series: Twin pregnant with short cervix</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Case #1</th><th align="center" valign="middle" >Case #2</th><th align="center" valign="middle" >Case #3</th><th align="center" valign="middle" >Case #4</th><th align="center" valign="middle" >Case #5</th><th align="center" valign="middle" >Case #6</th></tr></thead><tr><td align="center" valign="middle" >Maternal Age</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >41</td></tr><tr><td align="center" valign="middle" >Gravidity and parity</td><td align="center" valign="middle" >G2 P1*</td><td align="center" valign="middle" >G1</td><td align="center" valign="middle" >G1</td><td align="center" valign="middle" >G1</td><td align="center" valign="middle" >G2 P1*</td><td align="center" valign="middle" >G1A1</td></tr><tr><td align="center" valign="middle" >Cervical length (mm)</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >Cervical funneling</td><td align="center" valign="middle" >Yes (25 mm)</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Amniotic fluid sludge</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Chorionicity</td><td align="center" valign="middle" >Dichorionic, diamniotic</td><td align="center" valign="middle" >Dichorionic, diamniotic</td><td align="center" valign="middle" >Dichorionic, diamniotic</td><td align="center" valign="middle" >Monochorionic, diamniotic</td><td align="center" valign="middle" >Monochorionic, diamniotic</td><td align="center" valign="middle" >Monochorionic, diamniotic</td></tr><tr><td align="center" valign="middle" >Assisted reproduction procedure or ovulation induction</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >In vitro fertilisation</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >In vitro fertilisation</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >In vitro fertilisation</td></tr><tr><td align="center" valign="middle" >Risk factors</td><td align="center" valign="middle" >Bacterial vaginosis</td><td align="center" valign="middle" >Thrombophilia</td><td align="center" valign="middle" >Bacterial vaginosis</td><td align="center" valign="middle" >Cervical conization</td><td align="center" valign="middle" >Family stress</td><td align="center" valign="middle" >Thrombophilia</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Urinary infection</td><td align="center" valign="middle" >Anemia</td><td align="center" valign="middle" >Urinary infection</td><td align="center" valign="middle" >Thrombophilia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Urinary infection</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bleeding in the first trimester</td><td align="center" valign="middle" >Hypothyroidism</td><td align="center" valign="middle" >Bleeding in the first trimester</td><td align="center" valign="middle" >Hypothyroidism</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Family stress and depression</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Family stress and depression</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gestational age at cervical pessary insertion (completed weeks)</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >18</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >Gestational age of birth (completed weeks)</th><th align="center" valign="middle" >29</th><th align="center" valign="middle" >34</th><th align="center" valign="middle" >26</th><th align="center" valign="middle" >34</th><th align="center" valign="middle" >33</th><th align="center" valign="middle" >28</th></tr></thead><tr><td align="center" valign="middle" >Pregnancy Outcomes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gestational age at admission (completed weeks)</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Spontaneous labor</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No****</td><td align="center" valign="middle" >No****</td><td align="center" valign="middle" >No****</td></tr><tr><td align="center" valign="middle" >Tocolytics</td><td align="center" valign="middle" >Atosiban</td><td align="center" valign="middle" >Atosiban, nifedipine</td><td align="center" valign="middle" >Atosiban</td><td align="center" valign="middle" >Nifedipine</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >GBS</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Fetal evolution</td><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >AFD</td><td align="center" valign="middle" >FGR and marginal cord insertion</td><td align="center" valign="middle" >AFD, FGR</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >Sludge empyrical treatment with clindamycin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Gestational diabetes control</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Premature rupture membranes</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neonatal Outcomes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Birth weight (g)</td><td align="center" valign="middle" >1350 and 1253</td><td align="center" valign="middle" >2020 and 1826</td><td align="center" valign="middle" >680 and 750</td><td align="center" valign="middle" >1678 and 1470</td><td align="center" valign="middle" >1886 and 1970</td><td align="center" valign="middle" >686 and 916</td></tr><tr><td align="center" valign="middle" >5-minute Apgar scores</td><td align="center" valign="middle" >9 and 10</td><td align="center" valign="middle" >10 and 10</td><td align="center" valign="middle" >9 and 9</td><td align="center" valign="middle" >9 and 9</td><td align="center" valign="middle" >10 and 10</td><td align="center" valign="middle" >10 and 8</td></tr><tr><td align="center" valign="middle" >NICU stay (days)</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >17 and 142</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >89 and 66</td></tr><tr><td align="center" valign="middle" >Twin pair neonatal outcomes</td><td align="center" valign="middle" >Both discharged home without major sequelae</td><td align="center" valign="middle" >Both discharged home without major sequelae</td><td align="center" valign="middle" >Twin I: gastroschisis, fetal sepsis. Died after 17 days</td><td align="center" valign="middle" >Fetal sepsis. Both discharged home without major sequelae</td><td align="center" valign="middle" >Both discharged home without major sequelae</td><td align="center" valign="middle" >Twin I: fetal sepsis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Twin II: fetal sepsis. Discharged home without serious sequelae</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Both discharged home without major sequelae</td></tr></tbody></table></table-wrap></table-wrap-group><p>NICU: neonatal intensive care unit. GBS: Group B Streptococcal colonisation. *Term delivery. **Fetal growth restriction. ***Abnormal fetal Doppler. ****Delivey indicated by medical reasons.</p><p>(range 26 - 34), half of them due to spontaneous onset of labor. In three cases the decision to deliver was due to fetal conditions and not due to preterm labor: one because of non-reassuring well-being test and two because of intrauterine growth retardation associated to abnormal Doppler ultrasound. The mean length of pregnancy since pessary insertion to birth was 9 weeks (range 2 to 17 weeks).</p><p>All pregnancies were delivered by caesarean, and all patients received antenatal corticosteroids for fetal pulmonary maturation before delivery. Patients with a positive group B streptococcal colonisation test at the onset of preterm labor received antimicrobial prophylaxis. The neonatal mortality rate was 8%, and the newborns who deceased had important anatomical problems (gastroschisis).</p><p>The risk of spontaneous preterm birth increases significantly with the number of risk factors for prematurity [<xref ref-type="bibr" rid="scirp.88267-ref12">12</xref>] . In our group of patients, we observed that in the two cases where birth occurred before 28 weeks there were multiple factors related to prematurity such as polyhydramnios, hypothyroidism, first-trimester bleeding, bacterial vaginosis, urinary tract infection, amniotic fluid sludge, cervical funneling and/or fetal malformations [<xref ref-type="bibr" rid="scirp.88267-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref15">15</xref>] .</p><p>The prevention of premature birth should be carried out throughout the prenatal visits by screening all the possible associated conditions in order to provide proper and immediate treatment. The use of tocolytics, corticosteroids and antibiotic therapy may have contributed significantly to the success of the presented cases since, with the exception of fetuses with major malformations, all babies were discharged without serious sequelae.</p></sec><sec id="s4"><title>4. Conclusions</title><p>The prevention of prematurity in twins is challenging, and the association of different strategies is frequently used. Nevertheless, it still needs to be studied more deeply. In order to significantly reduce prematurity incidence, we consider the CL measurement of fundamental importance in all twin pregnancies [<xref ref-type="bibr" rid="scirp.88267-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref16">16</xref>] , as well as the use of progesterone at a dose of 400 mg/day in cases of short cervix [<xref ref-type="bibr" rid="scirp.88267-ref11">11</xref>] .</p><p>Different authors assert that cervical pessary may be useful to reduce neonatal morbidity and mortality in the subgroup of women with TPSC without any serious adverse effects [<xref ref-type="bibr" rid="scirp.88267-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref6">6</xref>] . Nevertheless, the pessaries used on this case series were manufactured by Ingamed<sup>&#210;</sup> (“Ingamed-Materiais M&#233;dico Hospitalares” n.d.), which may differ from the Arabin<sup>&#210;</sup> pessaries (“ARABIN<sup>&#210;</sup> Cerclage Pessar Perforiert” n.d.) described on most studies [<xref ref-type="bibr" rid="scirp.88267-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.88267-ref18">18</xref>] . The Arabin<sup>&#210;</sup> pessary is not easily available in Brazil, though. The lack of a control group without pessary insertion does not allow drawing any conclusion about its efficiency from this study, but it is important to highlight that this is the first publication utilizing the Ingamed<sup>&#210;</sup> Brazilian pessary for preterm delivery prevention.</p><p>Considering the high morbidity and mortality associated to prematurity, especially when extreme, the reduction in the number of days of neonatal intensive care unit stay is important to reduce economic, family and social costs. Despite no official Brazilian recommendation for measurement of cervix in twin pregnancies, screening for asymptomatic cervical shortening in those patients seems to be necessary, once there probably are effective interventions that could be established. In this context, the pessary seems to be at least a safe measure to extend pregnancy length on selected TPSC.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Vettorazzi, J., Salazar, C.C., Val&#233;rio, E.G., Isotton, A.L., Petermann, A., Rosa, M.W. and Rostirolla, G.F. (2018) First Experience Using Brazilian Ingamed<sup>&#174;</sup> Cervical Pessary in Twin Pregnancy: A Case Series. Open Journal of Obstetrics and Gynecology, 8, 1282-1288. https://doi.org/10.4236/ojog.2018.813130</p></sec></body><back><ref-list><title>References</title><ref id="scirp.88267-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hamilton, B.E., Martin, J.A. and Ventura, S.J. (2013) Births: Preliminary Data for 2012. National Vital Statistics Reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 62, 1-20.</mixed-citation></ref><ref id="scirp.88267-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">El-Gharib, M.N. and Albehoty, S.B. (2017) Transvaginal Cervical Length Measurement at 22- to 26-Week Pregnancy in Prediction of Preterm Births in Twin Pregnancies. The Journal of Maternal-Fetal &amp; Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, The Federation of Asia and Oceania Perinatal Societies, The International Society of Perinatal Obstetricians, 30, 729-732. https://doi.org/10.1080/14767058.2016.1183636</mixed-citation></ref><ref id="scirp.88267-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Makrydimas, G. and Sotiriadis, A. (2014) Prediction of Preterm Birth in Twins. Best Practice &amp; Research. Clinical Obstetrics &amp; Gynaecology, 28, 265-272.  
https://doi.org/10.1016/j.bpobgyn.2013.11.007</mixed-citation></ref><ref id="scirp.88267-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kindinger, L.M., Poon, L.C., Cacciatore, S., MacIntyre, D.A., Fox, N.S., Schuit, E., Mol, B.W., et al. (2016) The Effect of Gestational Age and Cervical Length Measurements in the Prediction of Spontaneous Preterm Birth in Twin Pregnancies: An Individual Patient Level Meta-Analysis. BJOG: An International Journal of Obstetrics and Gynaecology, 123, 877-884.  
https://doi.org/10.1111/1471-0528.13575</mixed-citation></ref><ref id="scirp.88267-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Huras, H., Kalinka, J. and Debski, R. (2017) Short Cervix in Twin Pregnancies: Current State of Knowledge and the Proposed Scheme of Treatment. Ginekologia Polska, 88, 626-632. https://doi.org/10.5603/GP.a2017.0112</mixed-citation></ref><ref id="scirp.88267-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hooft, J., van der Lee, J.H., Opmeer, B.C., van Wassenaer-Leemhuis, A.G., van Baar, A.L., Bekedam, D.J., Steenis, L.J.P., et al. (2018) Pessary for Preterm Birth Prevention in Twin Pregnancy with Short Cervix: 3-Year Follow-Up Study. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. Wiley Online Library.  
https://onlinelibrary.wiley.com/doi/abs/10.1002/uog.19029</mixed-citation></ref><ref id="scirp.88267-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Khalil, A., Rodgers, M., Baschat, A., Bhide, A., Gratacos, E., Hecher, K., Kilby, M.D., et al. (2016) ISUOG Practice Guidelines: Role of Ultrasound in Twin Pregnancy. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 47, 247-263.  
https://doi.org/10.1002/uog.15821</mixed-citation></ref><ref id="scirp.88267-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Saccone, G., Rust, O., Althuisius, S., Roman, A. and Berghella, V. (2015) Cerclage for Short Cervix in Twin Pregnancies: Systematic Review and Meta-Analysis of Randomized Trials Using Individual Patient-Level Data. Acta Obstetricia et Gynecologica Scandinavica, 94, 352-358. https://doi.org/10.1111/aogs.12600</mixed-citation></ref><ref id="scirp.88267-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Goya, M., de la Calle, M., Pratcorona, L., Merced, C., Rodó, C., Munoz, B., Juan, M., et al. (2016) Cervical Pessary to Prevent Preterm Birth in Women with Twin Gestation and Sonographic Short Cervix. Obstetric Anesthesia Digest, 36, 208-209.  
https://doi.org/10.1097/01.aoa.0000504739.20530.02</mixed-citation></ref><ref id="scirp.88267-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Alfirevic, Z., Owen, J., Carreras Moratonas, E., Sharp, A.N., Szychowski, J.M. and Goya, M. (2013) Vaginal Progesterone, Cerclage or Cervical Pessary for Preventing Preterm Birth in Asymptomatic Singleton Pregnant Women with a History of Preterm Birth and a Sonographic Short Cervix. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 41, 146-151. https://doi.org/10.1002/uog.12300</mixed-citation></ref><ref id="scirp.88267-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Romero, R., Conde-Agudelo, A., El-Refaie, W., Rode, L., Brizot, M.L., Cetingoz, E., Serra, V., et al. (2017) Vaginal Progesterone Decreases Preterm Birth and Neonatal Morbidity and Mortality in Women with a Twin Gestation and a Short Cervix: An Updated Meta-Analysis of Individual Patient Data. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 49, 303-314. https://doi.org/10.1002/uog.17397</mixed-citation></ref><ref id="scirp.88267-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Spiegelman, J., Booker, W., Gupta, S., Lam-Rochlin, J., Rebarber, A., Saltzman, D.H., Monteagudo, A. and Fox, N.S. (2016) The Independent Association of a Short Cervix, Positive Fetal Fibronectin, Amniotic Fluid Sludge, and Cervical Funneling with Spontaneous Preterm Birth in Twin Pregnancies. American Journal of Perinatology, 33, 1159-1164. https://doi.org/10.1055/s-0036-1585582</mixed-citation></ref><ref id="scirp.88267-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kalinderi, K., Delkos, D., Kalinderis, M., Athanasiadis, A. and Kalogiannidis, I. (2018) Urinary Tract Infection during Pregnancy: Current Concepts on a Common Multifaceted Problem. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, 38, 448-453.  
https://doi.org/10.1080/01443615.2017.1370579</mixed-citation></ref><ref id="scirp.88267-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Dias, T.Z., Passini Jr., R., Tedesco, R.P., Lajos, G.J., Rehder, P.M., Nomura, M.L., Costa, M.L., et al. (2017) Evaluation of Prenatal Corticosteroid Use in Spontaneous Preterm Labor in the Brazilian Multicenter Study on Preterm Birth (EMIP). International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 139, 222-229.  
https://doi.org/10.1002/ijgo.12297</mixed-citation></ref><ref id="scirp.88267-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Boyer, A., Cameron, L., Munoz-Maldonado, Y., Bronsteen, R., Comstock, C.H., Lee, W. and Goncalves, L.F. (2014) Clinical Significance of Amniotic Fluid Sludge in Twin Pregnancies with a Short Cervical Length. American Journal of Obstetrics and Gynecology, 211, 506.e1-506.e9. https://doi.org/10.1016/j.ajog.2014.05.044</mixed-citation></ref><ref id="scirp.88267-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Goya, M., Carreras, E. and Cabero, L. (2016) Re: ISUOG Practice Guidelines: Role of Ultrasound in Twin Pregnancy. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 48, 669-670. https://doi.org/10.1002/uog.17218</mixed-citation></ref><ref id="scirp.88267-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Dr. Arabin (n.d.) ARABIN&lt;sup&gt;&amp;reg&lt;/sup&gt; Cerclage Pessar Perforiert. 
http://www.dr-arabin.de/cerclage-pessare</mixed-citation></ref><ref id="scirp.88267-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ingamed-Materiais Médico Hospitalares (n.d.)  
http://www.ingamed.com.br/produtos-detalhe/51/pessario-am</mixed-citation></ref></ref-list></back></article>